13-31761742-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_130806.5(RXFP2):c.260C>T(p.Ala87Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 1,612,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130806.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXFP2 | NM_130806.5 | c.260C>T | p.Ala87Val | missense_variant | 3/18 | ENST00000298386.7 | NP_570718.1 | |
RXFP2 | NM_001166058.2 | c.260C>T | p.Ala87Val | missense_variant | 3/17 | NP_001159530.1 | ||
RXFP2 | XM_017020389.2 | c.260C>T | p.Ala87Val | missense_variant | 3/15 | XP_016875878.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXFP2 | ENST00000298386.7 | c.260C>T | p.Ala87Val | missense_variant | 3/18 | 1 | NM_130806.5 | ENSP00000298386.2 | ||
RXFP2 | ENST00000380314.2 | c.260C>T | p.Ala87Val | missense_variant | 3/17 | 1 | ENSP00000369670.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000167 AC: 42AN: 251228Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135776
GnomAD4 exome AF: 0.0000843 AC: 123AN: 1459858Hom.: 0 Cov.: 29 AF XY: 0.0000757 AC XY: 55AN XY: 726400
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.260C>T (p.A87V) alteration is located in exon 3 (coding exon 3) of the RXFP2 gene. This alteration results from a C to T substitution at nucleotide position 260, causing the alanine (A) at amino acid position 87 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at